Evidence map›Paper›PMID 28437796›Full record

ArticleAnnals of internal medicine2017

Toward Optimal Control of Hepatitis C Virus Infection in Persons With Substance Use Disorders.

Andrew H Talal, Dave L Thomas, Jessica L Reynolds, Jag H Khalsa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of internal medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Epidemiology of Hepatitis C in Delaware.Delaware journal of public health · 2020
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew H TalalFrom the University at Buffalo, The State University of New York, Buffalo, New York; Johns Hopkins University School of Medicine, Baltimore, Maryland; and the National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
Dave L ThomasFrom the University at Buffalo, The State University of New York, Buffalo, New York; Johns Hopkins University School of Medicine, Baltimore, Maryland; and the National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
Jessica L ReynoldsFrom the University at Buffalo, The State University of New York, Buffalo, New York; Johns Hopkins University School of Medicine, Baltimore, Maryland; and the National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.
Jag H KhalsaFrom the University at Buffalo, The State University of New York, Buffalo, New York; Johns Hopkins University School of Medicine, Baltimore, Maryland; and the National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.

Funding

Virology/Immunology CoreP30AI078498 · NIAID · UNIVERSITY OF ROCHESTER · PI DEWHURST, STEPHEN · 2008 to 2018
$14.6M
NIAID NIH HHS P30 AI078498
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FemaleHepatitis B VaccinesHepatitis CHumansMaleReferral and ConsultationSubstance-Related DisordersHepatitis B Vaccines

Identifiers

PMID28437796
PMCPMC10530641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.